EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancing brain immunotherapy through functional nanomaterials

Bhanu Nirosha Yalamandala, Thi My Hue Huynh, Hui-Wen Lien, Wan-Chi Pan, Hoi Man Iao, Thrinayan Moorthy, Yun-Hsuan Chang, Shang-Hsiu Hu

Drug Delivery and Translational Research · 2026

DOI: 10.1007/s13346-024-01778-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Delivery and Translational Research, 2026. Verfasst von Bhanu Nirosha Yalamandala und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, 300044, Hsinchu, Taiwan. Hauptthemen laut MEDLINE: Brain Neoplasms, Immunotherapy, Glioblastoma, Nanostructures. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan, National Tsing Hua University, National Health Research Institutes.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM), a highly aggressive brain tumor, poses significant treatment challenges due to its highly immunosuppressive microenvironment and the brain immune privilege. Immunotherapy activating the immune system and T lymphocyte infiltration holds great promise against GBM. However, the brain’s low immunogenicity and the difficulty of crossing the blood-brain barrier (BBB) hinder therapeutic efficacy. Recent advancements in immune-actuated particles for targeted drug delivery have shown the potential to overcome these obstacles. These particles interact with the BBB by rapidly and reversibly disrupting its structure, thereby significantly enhancing targeting and penetrating delivery. The BBB targeting also minimizes potential long-term damage. At GBM, the particles demonstrated effective chemotherapy, chemodynamic therapy, photothermal therapy (PTT), photodynamic therapy (PDT), radiotherapy, or magnetotherapy, facilitating tumor disruption and promoting antigen release. Additionally, components of the delivery system retained autologous tumor-associated antigens and presented them to dendritic cells (DCs), ensuring prolonged immune activation. This review explores the immunosuppressive mechanisms of GBM, existing therapeutic strategies, and the role of nanomaterials in enhancing immunotherapy. We also discuss innovative particle-based approaches designed to traverse the BBB by mimicking innate immune functions to improve treatment outcomes for brain tumors. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsImmunotherapyGlioblastomaNanostructuresHumansAnimalsBlood-Brain BarrierDrug Delivery SystemsTumor Microenvironment

Stichwörter der Autor:innen

Blood-brain barrierBrain tumorGlioblastomaImmunotherapyNanomaterials

Autor:innen und Institutionen

  • Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, 300044, Hsinchu, Taiwan.
  • Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, 300044, Hsinchu, Taiwan. shhu@mx.nthu.edu.tw.

Förderung

  • National Science and Technology Council, Taiwan
  • National Tsing Hua University
  • National Health Research Institutes

Zitieren

APA

Yalamandala, B. N., Huynh, T. M. H., Lien, H. W., Pan, W. C., Iao, H. M., Moorthy, T., Chang, Y. H., & Hu, S. H. (2026). Advancing brain immunotherapy through functional nanomaterials. Drug Delivery and Translational Research. https://doi.org/10.1007/s13346-024-01778-5

Vancouver

Yalamandala BN, Huynh TMH, Lien HW, Pan WC, Iao HM, Moorthy T, et al. Advancing brain immunotherapy through functional nanomaterials. Drug Delivery and Translational Research. 2026. doi:10.1007/s13346-024-01778-5

BibTeX
@article{Yalamandala2026,
  author = {Yalamandala, Bhanu Nirosha and Huynh, Thi My Hue and Lien, Hui-Wen and Pan, Wan-Chi and Iao, Hoi Man and Moorthy, Thrinayan and Chang, Yun-Hsuan and Hu, Shang-Hsiu},
  title = {Advancing brain immunotherapy through functional nanomaterials},
  journal = {Drug Delivery and Translational Research},
  year = {2026},
  doi = {10.1007/s13346-024-01778-5}
}
Kostenlos starten →